Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Wake Forest University Health Sciences
Brown University
University of Chicago
Fate Therapeutics
AstraZeneca
Rakuten Medical, Inc.
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Nurix Therapeutics, Inc.
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
University of Michigan Rogel Cancer Center
Iovance Biotherapeutics, Inc.
Akeso
Fudan University
Ohio State University Comprehensive Cancer Center
Lyvgen Biopharma Holdings Limited